Long-term follow-up of patients who received repeat-dose rituximab as maintenance therapy for ANCA-associated vasculitis
Objective. ANCA-associated vasculitis (AAV) is characterized by a chronic relapsing course. Rituximab (RTX) is an effective maintenance treatment; however, the long-term outcomes after its discontinuation are unclear. The aim of this study was to explore the long-term outcomes of AAV patients treated with repeatdose RTX maintenance therapy. Methods. AAV patients receiving a RTX treatment protocol consisting of an induction and maintenance phase were included. For initial remission...[Show more]
|Collections||ANU Research Publications|
|01_Alberici_Long-term_follow-up_of_2015.pdf||367.93 kB||Adobe PDF||Request a copy|
Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.